Leggio, M <br/><br/>
Low-dose aspirin for primary prevention of cardiovascular events in patients with diabetes: Benefit or risk?  [electronic resource] 

 -  Diabetes & metabolism  Jun 2018 
 - 217-225 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1878-1780 
<br/><br/><label>Standard No.: </label>10.1016/j.diabet.2017.11.002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aspirin--administration & dosage<br/>Cardiovascular Diseases--prevention & control<br/>Diabetes Complications--prevention & control<br/>Fibrinolytic Agents--administration & dosage<br/>Humans<br/>Primary Prevention<br/>Risk Factors